National Comprehensive Cancer Network

About NCCN

NCCN Publishes Lung Cancer Guidelines for use in Middle East & North Africa

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

The National Comprehensive Cancer Network® (NCCN®) recently posted the updated Middle East & North Africa (MENA) Editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer, Version 4.2017.

NCCN continues to work closely with the MENA Coordinating Office for NCCN Collaborations, situated at the King Abdulaziz Medical City in Riyadh, Saudi Arabia. This recent adaptation is part of a larger endeavor by the MENA Coordinating Office for NCCN and NCCN to adapt the NCCN Guidelines® for several disease types, including Breast, Colon, Hepatobiliary, and Prostate Cancers, as well as Lymphomas.

NCCN regularly collaborates to create and distribute foreign editions, regional adaptations, and consensus statements of the NCCN Guidelines, which are NCCN Guidelines derivatives that allow for consideration of metabolic differences in populations, local accessibility, and regulatory status of health care technologies used in cancer care in the specified country or region. For additional information on NCCN Global Programs, visit NCCN.org/global.

If you would like to learn more about adaptations of the NCCN Guidelines, please contact Jorge Bacigalupo.